Huancheng Tang

Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder Cancer.

G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K/Akt Activation in Bladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 21, 2023

NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer.

NFYC-37 promotes tumor growth by activating the mevalonate pathway in bladder cancer.

Journal: Cell reports

Published: October 05, 2022

'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.

'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 27, 2022

Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.

Knockdown of ZBTB11 impedes R-loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer.

Journal: Cell proliferation

Published: March 09, 2022

RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ.

RITA1 drives the growth of bladder cancer cells by recruiting TRIM25 to facilitate the proteasomal degradation of RBPJ.

Journal: Cancer science

Published: November 18, 2021

Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.

Journal: Cancer medicine

Published: June 06, 2021

CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer.

CircCA12 Promotes Malignant Process via Sponging miR-1184 and Upregulating RAS Family in Bladder Cancer.

Journal: Frontiers in genetics

Published: February 04, 2021

[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo.

[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 11, 2020

Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway.

Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway.

Journal: Oncology letters

Published: December 06, 2018

Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.

Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal cell carcinoma cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: September 28, 2017

JS-K enhances chemosensitivity of prostate cancer cells to Taxol via reactive oxygen species activation.

JS-K enhances chemosensitivity of prostate cancer cells to Taxol via reactive oxygen species activation.

Journal: Oncology letters

Published: September 20, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026